Phuturdex › Diseases › Abdominal neoplasm
Drugs in development · updated 13 November 2026
Abdominal neoplasm: drugs in development
What it is
New abnormal growth of tissue in the ABDOMEN.
Source: NLM MeSH (U.S. National Library of Medicine), descriptor D000008, meshb.nlm.nih.gov · public domain · downloaded on 13 November 2026.
As of 13 November 2026 there are 26 active clinical trials (recruiting or ongoing, phases I–III) on 33 drugs for abdominal neoplasm. 9 are experimental, that is not yet approved in the United States.
In Phuturdex every drug has its map of sites in Europe, every trial and its alerts, and you get an email when something changes. Full access free until 31 March 2027, no card needed.
Experimental drugs
Not yet approved by the US FDA for any indication.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| GEH300079 | II–III | 1 | NCT07219238 |
| OregovomabMAb-B43.13 | III | 1 | NCT04498117 |
| FianlimabREGN3767, WHO 11182 | II | 1 | NCT06787612 |
| GalunisertibLY2157299 | I–II | 1 | NCT05700656 |
| Radspherin | II | 1 | NCT06504147 |
| REGN10597 | II | 1 | NCT06787612 |
| STAR0602 | I–II | 1 | NCT05592626 |
| UbamatamabREGN4018 | II | 1 | NCT06787612 |
| Eftilagimod AlfaIMP321 | I | 1 | NCT03252938 |
Sorted by most advanced phase and number of active trials.
Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| PaclitaxelTaxol, Paxlitaxel | II–III | 6 | NCT07001748 |
| BevacizumabAvastin, bevacizuma | III | 3 | NCT07213804 |
| Nab-paclitaxelAbraxane, Nab-placlitaxel | III | 2 | NCT05257408 |
| RelacorilantLifyorli (Copackaged)®, Lifyorli® | III | 2 | NCT05257408 |
| CarboplatinParaplatin, Kyxata® | III | 1 | NCT04498117 |
| LetrozoleFemara, C17H11N5 | III | 1 | NCT04111978 |
| Mitomycin CMitomycin, Jelmyto | II | 5 | NCT04107077 |
| CisplatinCis Platinum, Cisplatine | II | 4 | NCT04107077 |
| Fluorouracil5-Fluorouracil, Fluoruracil | II | 4 | NCT04840264 |
| OxaliplatinOxaliplatine, Oxaliplain | II | 3 | NCT04840264 |
| DocetaxelTaxotere, Beizray® | I–II | 2 | NCT05592626 |
| IrinotecanOnivyde, CPT-11 | I–II | 2 | NCT05592626 |
| LeucovorinFolinic acid, l-leucovorin | II | 2 | NCT04762953 |
| Sodium ThiosulfatePedmark®, Pedmarqsi® | II | 2 | NCT03127774 |
| CapecitabineXeloda, Capectitabine | I–II | 1 | NCT05700656 |
Sorted by most advanced phase and number of active trials. Showing 15 of 24 drugs.
Sites in Europe
251 sites of the active trials in 18 European countries, 160 recruiting.
- Germany48
- Italy31
- Spain29
- Switzerland26
- France25
- Belgium18
- United Kingdom14
- Hungary11
- and 10 more
Sites declared by the sponsors on ClinicalTrials.gov; region worked out by Phuturdex from the geographic point. The list of sites with city and recruitment status is in the app. See the sites →
All 33 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Peritoneal neoplasm 32 drugs
- Ovarian neoplasm 420 drugs
- Fallopian tube neoplasm 124 drugs
- Colorectal neoplasm 587 drugs
- Appendiceal neoplasm 28 drugs
- Stomach neoplasm 328 drugs
- Metastasis 491 drugs
- Gastrointestinal neoplasm 818 drugs
- Neoplasm 3,379 drugs
- Ovarian epithelial carcinoma 63 drugs
- Uterine neoplasm 394 drugs
- Adrenocortical carcinoma 28 drugs
Broader categories
- Skin disease 1,346 drugs
- Skin and connective tissue diseases 1,503 drugs
- Stomatognathic disease 244 drugs
- Urologic Diseases 766 drugs
- Female urogenital disease 1,195 drugs
- Female urogenital diseases and pregnancy complications 1,234 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 13 November 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D000008 “Abdominal Neoplasms”.